Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer

Abstract

BackgroundAberrant DNA methylation has been widely investigated in sporadic colorectal carcinomas (CRCs), and extensive work has been performed to characterize different methylation profiles of CRC. Less information is available about the role of epigenetics in hereditary CRC and about the possible clinical use of epigenetic biomarkers in CRC, regardless of the etiopathogenesis. Long interspersed nucleotide element 1 (LINE-1) hypomethylation and gene-specific hypermethylation of 38 promoters were analyzed in multicenter series of 220 CRCs including 71 Lynch (Lynch colorectal cancer with microsatellite instability (LS-MSI)), 23 CRCs of patients under 40 years in which the main inherited CRC syndromes had been excluded (early-onset colorectal cancer with microsatellite stability (EO-MSS)), and 126 sporadic CRCs, comprising 28 cases with microsatellite instability (S-MSI) and 98 that were microsatellite stable (S-MSS). All tumor methylation patterns were integrated with clinico-pathological and genetic characteristics, namely chromosomal instability (CIN), TP53 loss, BRAF, and KRAS mutations.ResultsLS-MSI mainly showed absence of extensive DNA hypo- and hypermethylation. LINE-1 hypomethylation was observed in a subset of LS-MSI that were associated with the worse prognosis. Genetically, they commonly displayed G:A transition in the KRAS gene and absence of a CIN phenotype and of TP53 loss. S-MSI exhibited a specific epigenetic profile showing low rates of LINE-1 hypomethylation and extensive gene hypermethylation. S-MSI were mainly characterized by MLH1 methylation, BRAF mutation, and absence of a CIN phenotype and of TP53 loss. By contrast, S-MSS showed a high frequency of LINE-1 hypomethylation and of CIN, and they were associated with a worse prognosis. EO-MSS were a genetically and epigenetically heterogeneous group of CRCs. Like LS-MSI, some EO-MSS displayed low rates of DNA hypo- or hypermethylation and frequent G:A transitions in the KRAS gene, suggesting that a genetic syndrome might still be unrevealed in these patients. By contrast, some EO-MSS showed similar features to those observed in S-MSS, such as LINE-1 hypomethylation, CIN, and TP53 deletion. In all four classes, hypermethylation of ESR1, GATA5, and WT1 was very common.ConclusionsAberrant DNA methylation analysis allows the identification of different subsets of CRCs. This study confirms the potential utility of methylation tests for early detection of CRC and suggests that LINE-1 hypomethylation may be a useful prognostic marker in both sporadic and inherited CRCs.Electronic supplementary materialThe online version of this article (doi:10.1186/s13148-015-0165-2) contains supplementary material, which is available to authorized users.

Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis

“…Our findings suggest a role for MSH2 in initiating early ETBF-mediated epigenetic alterations and maintaining DNA methylation alterations that occur in the ETBF-induced tumors. A recent study demonstrated that MSI tumors from patients with Lynch syndrome, a disease in which patients harbor genetic mutations in MMR genes and eventually develop CRC, have less DNA hypomethylation and fewer regional hypermethylation alterations (49), analogous to what we observed in our study.…”

Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics

“…(ThermoFisher Scientific, USA). We preliminarily analysed 150 control samples of MMR-proficient colorectal cancers to validate the specificity of the test 14 15. A tumour was considered MSI when at least two microsatellite loci were unstable, showing insertion/deletion of at least 3 bp (see online supplementary table S1, figure 1).…”

Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome

“…17 A sample was classified as methylated when CpG sites in the Deng-C region exhibited methylation. All data obtained with MS-MLPA analysis were confirmed by bisulfate pyrosequencing of the Deng-C region, as previously described by Sahnane.…”